A newly identified mechanism lends credence to the idea that MS may be treatable by targeting EBV-infected B-cells, a study found.
News Medical on MSN
Brain organoids reveal glioblastoma's secrets and therapy resistance
UCLA scientists have developed advanced miniature 3D tumor organoid models that make it possible to study glioblastoma tumors ...
UCLA scientists have developed advanced miniature 3D tumor organoid models that make it possible to study glioblastoma tumors ...
AZoLifeSciences on MSN
New epigenetic catalog helps explain individual differences in immune responses
The COVID-19 pandemic gave us tremendous perspective on how wildly symptoms and outcomes can vary between patients experiencing the same infection.
Targeted therapies have been moved forward in the treatment of both pemphigus and pemphigoid diseases, a factor behind an urgency for rapid diagnosis.
AZoLifeSciences on MSN
Rare EBV-driven B cell event may spark multiple sclerosis onset
Autoimmune diseases such as multiple sclerosis arise when the immune system turns against the body itself.
Novartis CEO Vas Narasimhan is doubling down on a growth forecast for 2026, even as the Swiss drugmaker’s fourth-quarter ...
The COVID-19 pandemic gave us tremendous perspective on how wildly symptoms and outcomes can vary between patients ...
The COVID-19 pandemic gave us tremendous perspective on how wildly symptoms and outcomes can vary between patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results